eIF2alpha Dephosphorylation Threshold Prevents Pro-Apoptotic ATF4/CHOP Activation
🧪 Overview
Low-dose trazodone reduces phosphorylation of eIF2alpha, shifting translational control away from ATF4-dependent pro-apoptotic gene expression while preserving adaptive stress response genes. This creates a stress-resilient neuronal phenotype resistant to A-beta-mediated apoptosis. However, human AD brain tissue shows sustained PERK activation that correlates with cognitive decline, and direct PERK inhibitors produced pancreatic toxicity and were abandoned. The mechanistic chain from trazodone to eIF2alpha dephosphorylation via sigma-1 is long and uncertain.
🧬 Mechanism
Curated pathway from expert analysis
flowchart TD
A["Low-Dose Trazodone<br/>Integrated Stress Response"]
B["p-eIF2alpha Ser51<br/>Phosphorylation Reduced"]
C["ATF4 Translation<br/>Attenuated"]
D["CHOP DDIT3 Pro-Apoptotic<br/>Gene Expression Reduced"]
E["Adaptive Stress Response<br/>Genes Preserved"]
F["Stress-Resilient Neuronal<br/>Phenotype"]
G["Resistance to Abeta-Mediated<br/>Apoptosis"]
A --> B
B --> C
C --> D
D --> F
B --> E
E --> F
F --> G
style A fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7
style B fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style D fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — P-EIF2ALPHA
No curated PDB or AlphaFold mapping for P-EIF2ALPHA yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for p-eIF2alpha (Ser51), ATF4, CHOP (DDIT3) from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for p-eIF2alpha (Ser51), ATF4, CHOP (DDIT3).
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF primary cortical neurons from APP/PS1 mice are treated with trazodone (10 mg/kg i.p., 14 days) while sigma-1 receptor is pharmacologically blocked (BD1063, 5 mg/kg i.p. co-administered), THEN p-eIF | Sigma-1 antagonism will block trazodone-induced eIF2alpha dephosphorylation (p-eIF2alpha/total eIF2alpha ratio restored to vehicle levels), preventing downstrea | — no observation — | pending | 0.65 |
| IF human iPSC-derived cortical neurons (AD genotype, 3突变 carriers) are treated with sub-threshold trazodone (100 nM), threshold trazodone (1 μM), or Aβ42 oligomers (500 nM) for 48 hours, THEN neurons | A clear dose-response threshold for trazodone-mediated neuroprotection against Aβ toxicity, with the threshold dose achieving >50% reduction in CHOP (DDIT3) pro | — no observation — | pending | 0.58 |
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |